Budget Impact Analysis Of Empagliflozin (Jardiance®) In Type-2 Diabetes Patients With High Cardiovascular Risk In The South African Setting- A Retrospective Claims Database Analysis
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1189
https://www.valueinhealthjournal.com/article/S1098-3015(17)31523-1/fulltext
Title :
Budget Impact Analysis Of Empagliflozin (Jardiance®) In Type-2 Diabetes Patients With High Cardiovascular Risk In The South African Setting- A Retrospective Claims Database Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31523-1&doi=10.1016/j.jval.2017.08.1189
First page :
A608
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1140